What is the primary objective of **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 establishes criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures (§11.1(a)).** It applies to electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, ensuring authenticity, integrity, and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), and signature linking (§11.70).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**Organizations using electronic records in lieu of paper for predicate-rule-required records or relying on them for regulated activities must comply with FDA 21 CFR Part 11 (§11.1(b)).** This includes pharmaceutical, biotech, medical device firms, and CROs/CMOs handling GxP records like batch records or submissions accepted under docket 92S-0251; paper-reliant systems may be exempt if documented.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)), with systems and documentation readily available for FDA review; predicate rules remain enforceable.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**FDA 21 CFR Part 11 assessments should be performed periodically as part of change control, system lifecycle reviews, and risk-based validation.** FDA’s 2003 guidance recommends ongoing evaluation tied to predicate rules, with revalidation for changes affecting accuracy, audit trails (§11.10(e)), or signatures (§11.200).

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA Form 483 observations, warning letters, product holds, or enforcement actions for predicate rule violations.** Weak controls like inadequate audit trails or access (§11.10(d)) undermine data integrity, leading to batch rejections or injunctions, as seen in enforcement trends.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**Yes, FDA 21 CFR Part 11 controls can be mapped to frameworks like EU Annex 11 for aligned electronic record integrity.** Core elements (audit trails, signatures) overlap with ICH guidelines and GAMP 5, enabling risk-based harmonization while satisfying §11.10 closed/open system requirements.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step is to establish a formal applicability framework mapping predicate rules to records and documenting reliance on electronic vs. paper versions.** Per 2003 guidance, classify systems as closed (§11.3(b)(4)) or open (§11.3(b)(9)) via SOPs to define scope before controls.

What is the primary objective of **ISO 27018**?

**ISO 27018 provides a code of practice for protecting **personally identifiable information (PII)** in public clouds where the cloud service provider (CSP) acts as a PII processor.** It extends **ISO 27001** and **ISO 27002** with ~25–30 privacy-specific controls addressing multi-tenancy, subprocessor transparency, consent, purpose limitation, data minimization, breach notification, and restrictions on secondary PII use like advertising without consent. The 2025 edition aligns with **ISO 27002:2022** for modern cloud risks.

Who is legally or professionally required to comply with **ISO 27018**?

**ISO 27018 applies to public **CSPs** acting as **PII processors** for customers, including hyperscalers, regional providers, and sector-specific platforms.** It targets any organization processing PII in public cloud environments via multi-tenant infrastructure, regardless of size. Controllers use it for vendor due diligence, but it is processor-centric and not legally mandatory—adoption is driven by contracts, procurement, GDPR Article 28 alignment, and market expectations.

Does **ISO 27018** require an external audit or third-party certification?

**ISO 27018 does not offer standalone certification; controls are assessed within an **ISO 27001** audit by accredited bodies under **ISO/IEC 17021** and **ISO/IEC 27006*.** Auditors review implementation via the **Statement of Applicability (SoA)** during Stage 1 (documents) and Stage 2 (effectiveness) audits. Certificates reference both standards, valid for 3 years with annual surveillance.

How often should an assessment for **ISO 27018** be performed?

**ISO 27018 assessments occur annually via surveillance audits and every 3 years via full recertification within the **ISO 27001** cycle.** Gap analyses and internal audits should be risk-based and continuous, with continual improvement plans addressing changes in cloud services, subprocessors, or regulations like GDPR.

What are the consequences of non-compliance with **ISO 27018**?

**Non-compliance with ISO 27018 risks loss of customer trust, procurement delays, cyber insurance issues, and failure to meet processor obligations under laws like GDPR Article 28.** CSPs face rejected contracts, regulatory scrutiny on outsourcing, and competitive disadvantage, as buyers demand audited **SoA** transparency on subprocessors and breaches.

Can **ISO 27018** be mapped to other international frameworks?

**Yes, ISO 27018 maps directly to **ISO 27001 Annex A** (93 controls), **ISO 27002:2022**, **ISO 27017** (cloud security), and **ISO 27701** (PIMS for controllers/processors).** Controls align with GDPR Article 28 processor duties, OECD privacy guidelines, and **ISO 29100** principles like transparency and data minimization.

What is the first step to begin implementing **ISO 27018**?

**Conduct a gap analysis against current **ISMS**, **ISO 27001** controls, and ISO 27018 privacy objectives.** Engage stakeholders for discovery, review policies/contracts/technical configs, produce a prioritized remediation roadmap, and update the **SoA**—prerequisite is an existing **ISO 27001** foundation.

FDA 21 CFR Part 11 vs ISO 27018

Standards Comparison

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records and signatures equivalence

ISO 27018

Voluntary

2019

International code of practice for PII protection in public clouds

Quick Verdict

FDA 21 CFR Part 11 mandates trustworthy electronic records for life sciences, while ISO 27018 provides voluntary cloud PII privacy controls. Pharma firms comply with Part 11 for FDA enforcement; CSPs adopt 27018 for trust and procurement edge.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Establishes electronic records equivalence to paper records
Mandates secure time-stamped audit trails for changes
Requires risk-based system validation for integrity
Enforces unique multi-component electronic signatures
Distinguishes controls for closed versus open systems

Cloud Privacy

ISO 27018

ISO/IEC 27018:2025 Code of practice for PII in public clouds

Cost

€€€

Complexity

Medium

Implementation Time

6-12 months

Key Features

Tailored privacy controls for public cloud PII processors
Mandatory subprocessor transparency and disclosure
Prompt breach notification to PII controllers
Prohibits PII use for advertising without consent
Integrated within ISO 27001 certification audits

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation defining criteria for electronic records and electronic signatures to be trustworthy and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using computerized systems for predicate-rule records. The risk-based approach narrows scope to relied-upon electronic records, with enforcement discretion for some controls per 2003 guidance.

Key Components

**SubpartsGeneral provisions, electronic records controls (§11.10 closed, §11.30 open systems), electronic signatures (§11.50-11.300).
Core controls: validation, audit trails, access limits, operational/authority/device checks, training, accountability policies, signature linking/uniqueness.
Built on ALCOA+ principles for data integrity; no fixed control count, but emphasizes non-discretionary safeguards.
Compliance via validation lifecycle, no external certification.

Why Organizations Use It

Ensures regulatory acceptance of digital records, mitigates enforcement risks like warning letters, supports data integrity for quality decisions. Drives efficiency in inspections, CAPA, batch release; builds stakeholder trust in life sciences.

Implementation Overview

Risk-based CSV (GAMP5): scope records, classify systems, execute IQ/OQ/PQ, SOPs/training, supplier governance. Applies to pharma/biotech/devices using electronic records; multi-phase (6-24+ months), audited via FDA inspections.

ISO 27018 Details

What It Is

ISO/IEC 27018:2025 is a code of practice extending ISO/IEC 27001 and ISO/IEC 27002, focused on protecting personally identifiable information (PII) processed by public cloud service providers acting as PII processors. It addresses cloud-specific privacy risks like multi-tenancy and cross-border flows via a risk-based approach integrated into an Information Security Management System (ISMS).

Key Components

~25–30 additional privacy-specific controls covering consent, purpose limitation, data minimization, transparency, breach notification, and subprocessor management.
Built on principles including accuracy, retention limits, security safeguards, and accountability.
Implemented within ISO 27001 audits; no standalone certification.

Why Organizations Use It

Enhances trust, accelerates procurement, and aligns with GDPR, HIPAA.
Mitigates risks, supports cyber insurance, differentiates CSPs competitively.
Provides auditable evidence of processor diligence.

Implementation Overview

Gap analysis, update Statement of Applicability, enhance policies/contracts/technical controls.
Suits CSPs of all sizes globally; requires annual surveillance audits post-ISO 27001 certification.

Key Differences

Aspect	FDA 21 CFR Part 11	ISO 27018
Scope	Electronic records/signatures trustworthiness in FDA-regulated activities	PII protection in public cloud services as processor
Industry	Life sciences, pharma, medical devices (US-focused)	Cloud service providers worldwide, all sectors handling PII
Nature	Mandatory US FDA regulation with enforcement discretion	Voluntary code of practice extending ISO 27001
Testing	Risk-based system validation, FDA inspections	ISO 27001 audits assessing additional privacy controls
Penalties	Warning letters, fines, product holds, injunctions	Loss of certification, no direct legal penalties

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness in FDA-regulated activities

ISO 27018

PII protection in public cloud services as processor

Industry

FDA 21 CFR Part 11

Life sciences, pharma, medical devices (US-focused)

ISO 27018

Cloud service providers worldwide, all sectors handling PII

Nature

FDA 21 CFR Part 11

Mandatory US FDA regulation with enforcement discretion

ISO 27018

Voluntary code of practice extending ISO 27001

Testing

FDA 21 CFR Part 11

Risk-based system validation, FDA inspections

ISO 27018

ISO 27001 audits assessing additional privacy controls

Penalties

FDA 21 CFR Part 11

Warning letters, fines, product holds, injunctions

ISO 27018

Loss of certification, no direct legal penalties

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and ISO 27018

FDA 21 CFR Part 11 FAQ

ISO 27018 FAQ

You Might also be Interested in These Articles...

Your Compliance Command Center: How Modern Tools Orchestrate Cross-Departmental Adherence

Unlock your compliance command center with modern tools for real-time monitoring, automation & integrations across IT, HR, Legal & Finance. Slash non-compliance

Top 5 Reasons HITRUST CSF's MyCSF Platform Crushes Evidence Overload for R2 Assessments in Hybrid Cloud Environments

Explore top 5 advantages of HITRUST MyCSF for 1,400+ R2 controls in hybrid clouds. Slash docs by 30%, dodge under-scoping, achieve continuous compliance for hea

Top 10 Cost-Saving Hacks for CMMC Compliance: Budgeting Blueprints for Small DIB Suppliers

Slash CMMC costs 30-50% with top 10 hacks for small DIB suppliers. Enclave scoping, FedRAMP clouds, automation, POA&M tips & budgeting blueprints for Level 2 co

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

ISO 45001 vs ISO 22301

Discover ISO 45001 vs ISO 22301: OH&S leadership & worker safety vs business continuity resilience. Uncover key differences, PDCA integration benefits & implementation roadmap. Compare now!

APPI vs CCPA

APPI vs CCPA: Japan's consent-focused law with PPC oversight meets California's rights-driven regime (know, delete, opt-out). Master risks, ¥100M/$7.5K fines & frameworks. Comply globally now.

SAFe vs APRA CPS 234

SAFe vs APRA CPS 234: Align Scaled Agile with Australia's cyber security standard for regulated finance. Scale agility, ensure compliance & resilience. Explore key insights now!

FDA 21 CFR Part 11

ISO 27018

Quick Verdict

FDA 21 CFR Part 11

Key Features

ISO 27018

Key Features

Detailed Analysis

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

ISO 27018 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

ISO 27018 FAQ

What is the primary objective of ISO 27018?

Who is legally or professionally required to comply with ISO 27018?

Does ISO 27018 require an external audit or third-party certification?

How often should an assessment for ISO 27018 be performed?

What are the consequences of non-compliance with ISO 27018?

Can ISO 27018 be mapped to other international frameworks?

What is the first step to begin implementing ISO 27018?

You Might also be Interested in These Articles...

Your Compliance Command Center: How Modern Tools Orchestrate Cross-Departmental Adherence

Top 5 Reasons HITRUST CSF's MyCSF Platform Crushes Evidence Overload for R2 Assessments in Hybrid Cloud Environments

Top 10 Cost-Saving Hacks for CMMC Compliance: Budgeting Blueprints for Small DIB Suppliers

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

ISO 45001 vs ISO 22301

APPI vs CCPA

SAFe vs APRA CPS 234